Adaptimmune Therapeutics shares owned by Bryn Mawr Trust
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Bryn Mawr Trust
from 13F filings
Historical chart of Bryn Mawr Trust investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Bryn Mawr Trust consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Bryn Mawr Trust
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $79 | 604 | 0.13 |
| 2025-06-30 | $145 | 604 | 0.24 |
| 2025-03-31 | $118 | 604 | 0.20 |
| 2024-12-31 | $325 | 604 | 0.54 |
| 2024-09-30 | $573 | 604 | 0.95 |